Analysts' Actions: AGN FB KMB SO WEN

NEW YORK ( TheStreet) --

Saul Centers ( BFS) was downgraded to sell at TheStreet Ratings.

Allergan ( NOK) was downgraded at Goldman Sachs. Valuation call, based on a $110 price target, Goldman said.

Big Lots ( BIG) was downgraded to hold at TheStreet Ratings.

CH Robinson ( CHRW) was downgraded at Goldman Sachs to sell from neutral. $56 price target. Light truck names should lag the broader group, Goldman said.

Facebook ( FB) was upgraded at UBS to buy from neutral. Price target goes to $30. Current valuation is low and new monetization efforts are encouraging, UBS said.

Forest Laboratories ( FRX) was upgraded at Goldman Sachs to buy from neutral. $50 price target. See a higher potential for management to explore strategic options, Goldman said.

Fulton Financial ( FULT) was downgraded at Credit Suisse to underperform from neutral. $9.50 price target. Expect negative revisions to mortgage banking estimates, Credit Suisse said.

Kimberly-Clark ( KMB) was upgraded at BMO Capital Markets to market perform from underperform. Valuation call, based on a $96 price target, BMO Capital Markets said.

Medicines Company ( MDCO) was downgraded at Oppenheimer to perform from outperform. New analyst believes the stock is fully valued, Oppenheimer said.

Netgear ( NTGR) was upgraded at Wedbush to outperform from neutral. $38 price target. Company has potential catalysts for the second half and 2014, Wedbush said.

Questcor ( QCOR) was downgraded at Bank of America/Merrill Lynch to neutral from buy. $51 price target. Acthar could face increased competition, BofA/Merrill said.

Questcor was upgraded at Oppenheimer to outperform from perform. $57 price target. New analyst believes that Acthar can drive near-term growth, Oppenheimer said.

Southern Company ( SO) was upgraded at Citigroup to buy from neutral. The GP rate case will be manageable, and Vogtle cost overruns do not present a structural issue, Citi said.

SPX ( SPW) was downgraded at Citigroup to sell from neutral. Price target is $68. There is significant second half earnings risk and valuation is elevated, Citigroup said.

Total System ( TSS) was upgraded to outperform at Wells Fargo. Company shows unanticipated FCF growth and trades at a cheap multiple, Wells Fargo said.

If you liked this article you might like

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)

Centene: Cramer's Top Takeaways

Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round

The Pitney Bowes Transformation: Cramer's Top Takeaways

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways